Objective
This Fellowship will bring an outstanding researcher from Sweden to the UK to gain new scientific and career skills to position him to become a leading independent academic in the interface of chemistry and biology for translational Nanomedicine. The fellow will design a new class of biomimetic zipper nano-architecture, combining an MRI-enabled SPION scaffold with a zip-unzip, temperature and pH-responsive multi-arm polymer to defuse drug resistant cell functions. These approach could greatly benefit the current investigation of new and alternate therapeutic procedures to overcome drug resistance. The fellow will gain advanced training in translational designs of drugs for recognition and treatment of drug resistant system, and in state of the art techniques for studying such system.
Combined with the fellow's knowledge of nanoparticles in medicine, he will have a formidable skill set suited to designing nano-architectures for developing target-specific nano-drugs to push back frontiers in the battle against cancer. His excellent track record is in consistent with last two years performance with 4 publications (with cumulative IF>28) with leading publishers including Nature group, Wiley, Cell press etc., 1 cover page and cover story, one Keynote lecture and 2 international research competition awards (FEBS Young scientist forum and Nano Today, Elsevier ST award). A series of complementary career skills trainings will enhance the fellow's research management, leadership, presentation and teaching skills and make him an impressive and exciting candidate for an independent EU academic position.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences health sciences infectious diseases RNA viruses HIV
- medical and health sciences medical biotechnology nanomedicine
- engineering and technology medical engineering diagnostic imaging magnetic resonance imaging
- medical and health sciences basic medicine pharmacology and pharmacy drug resistance multidrug resistance
- medical and health sciences basic medicine pharmacology and pharmacy drug resistance antibiotic resistance
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF-EF-ST - Standard EF
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2015
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
CB2 1TN CAMBRIDGE
United Kingdom
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.